Trial
NCT03912428
Novel PET Radioligand as an Inflammatory Biomarker in Musculoskeletal Conditions
Phase ITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
National Institute of Mental Health (NIMH)
Collaborators
—
Condition
Myositis
Intervention
11C-MC1
Why stopped
due to difficulty with participant recruitment and data futility
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-09-16